Moolec Science (MLEC) EBT (2022 - 2024)

Moolec Science has disclosed EBT across 3 years of filings, most recently posting -$2.1 million for Q4 2024.

• EBT for Q4 2024 came in at -$2.1 million, down 6.28% year-over-year; the trailing twelve-month figure through Dec 2024 was -$33.3 million (down 134.84% YoY), and the FY2024 annual result was -$28.0 million, down 155.04% from the prior year.
• EBT came in at -$2.1 million for Q4 2024 at Moolec Science, down from -$1.9 million in the prior quarter.
• In the past five years, EBT ranged from a high of $99.8 million in Q2 2023 to a low of -$28.0 million in Q2 2024.
• The 3-year median for EBT is -$1.5 million (2023), against an average of $8.8 million.
• Across the five-year window, EBT soared 3470.4% in 2023 and plunged 255.65% in 2024, its largest moves.
• Moolec Science's EBT stood at $48.0 million in 2022, then slumped by 104.21% to -$2.0 million in 2023, then slipped by 6.28% to -$2.1 million in 2024.
• The last three EBT figures came in at -$2.1 million (Q4 2024), -$1.9 million (Q3 2024), and -$28.0 million (Q2 2024), per Business Quant data.